ClearPoint Neuro's (NASDAQ: CLPT ) stock has been under pressure in recent months after the company reported soft first-quarter results and raised additional capital. There is little reason for concern, though. Strong consumables growth highlights the underlying progress in ClearPoint's business, and system placements areRichard Durant is the leader of Narweena, an asset manager focused on finding market dislocations that are the result of a poor understanding of a businesses long-term prospects. Narweena b ...